The group, Translational genomics of colorectal cancer, is led by Jordi Camps. Camps is a graduate in biology and biochemistry from the Autonomous University of Barcelona, where he obtained his PhD in cellular biology. Next, he did a post-doctoral stay at the National Cancer Institute of the National Institutes of Health, in Bethesda, United States. He joined the IDIBAPS Gastrointestinal and Pancreatic Oncology Group in 2011 through a mobility grant from the AECC Scientific Foundation and, subsequently, secured a Miguel Servet contract.
The group’s goal is to understand the mechanisms of genomic instability and tumour heterogeneity and to use genetic information to discover molecular markers that enable improvement of the prognosis and prediction of the response to treatments in colorectal cancer.
Clínic Barcelona
Clínic Barcelona
Research
May 25 2021
IDIBAPS incorporates the ‘Translational genomics of colorectal cancer’ research group
The IDIBAPS governing board has approved the creation of a new research group. The decision is in response to the results of scientific evaluation, conducted by the ad hoc committee and the external scientific council, of researchers originating from the Miguel Servet programme, as described in the IDIBAPS research career document.
Jordi Camps is leader of the new 'Translational genomics of colorectal cancer' research group
